3'-Selenobisalanine" No Further a Mystery
The decrease in paclitaxel CL observed during the existence of zosuquidar triggered a boost in the time that the plasma paclitaxel concentration remains over 0.1 mol L−1, which is known being a marker of both equally toxicity (neutropenia) and efficacy [1]. Although the impact of zosuquidar to the toxicity of the clinically made use of dose of pa